MEGIN Revenue and Competitors

Espoo, FIN

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • MEGIN's estimated annual revenue is currently $7.5M per year.(i)
  • MEGIN's estimated revenue per employee is $100,000

Employee Data

  • MEGIN has 75 Employees.(i)
  • MEGIN grew their employee count by 10% last year.

MEGIN's People

NameTitleEmail/Phone
1
Director, Global Sales and MarketingReveal Email/Phone
2
Associate Director, Global Marketing and Sales (Service Contracts)Reveal Email/Phone
3
Project ManagerReveal Email/Phone
4
Software Development EngineerReveal Email/Phone
5
Development EngineerReveal Email/Phone
6
Assistant ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M38620%N/AN/A
#2
N/A7510%N/AN/A
#3
$7.5M7510%N/AN/A
Add Company

What Is MEGIN?

MEGIN, is the global leader for Magnetoencephalography (MEG) technology, a non-invasive, functional brain mapping solution for the diagnostic workup, treatment strategy and intervention of neurological conditions. Through innovation and passionate exploration of the endless possibilities, specialists from close to one hundred sites from around the world have used our MEG technology to study pathological and eloquent areas of the brain in patients diagnosed with neurological disorders such as epilepsy, brain tumors, autism, Alzheimer’s and vascular malformations. MEGIN’s global presence has revolutionized the ability to detect magnetic fields generated in the brain as information travels through a highly complex neural network. With this information physicians may be able to provide minimally invasive treatment options that can lead to improved outcomes for a better quality of life and minimize the potential for neurological deficits.

keywords:N/A

N/A

Total Funding

75

Number of Employees

$7.5M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A7510%N/A
#2
$16.7M7623%N/A
#3
N/A7726%N/A
#4
$16.2M7738%N/A
#5
$10.7M82-29%N/A